Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2021-03-05 | 2021-06-21 | 135171 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2024-09-27 | 2025-02-21 | 238841 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-10-10 | 2025-02-14 | 239819 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-10-18 | 2025-02-14 | 240627 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2024-10-24 | 2025-02-21 | 241072 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-11-07 | 2025-02-21 | 242214 |
| APO-RISPERIDONE | 4.0MG | TABLET | Resolved | 2024-12-19 | 2025-02-21 | 246062 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192803 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-05-19 | 2023-08-04 | 192821 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2023-07-13 | 2023-08-18 | 198480 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198486 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198489 |
| APO-RISPERIDONE | 2.0MG | TABLET | Resolved | 2023-09-22 | 2023-12-01 | 205002 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-11-10 | 2024-04-26 | 209957 |
| APO-RISPERIDONE | 1MG | SOLUTION | Resolved | 2018-03-27 | 2018-05-15 | 44114 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2022-07-05 | 2022-10-31 | 164083 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-07-29 | 2022-10-31 | 165674 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-07-29 | 2022-12-17 | 165677 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-03-11 | 2017-06-01 | 601 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2017-03-17 | 2017-06-01 | 3183 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
| APO-CITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60393 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-CLONAZEPAM - TAB 0.5MG | .5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60402 |
| APO-CYCLOBENZAPRINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60405 |
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
| APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | To be discontinued | 2018-09-07 | 2018-11-02 | 60423 |
| APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
| APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
| APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
| APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
| APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
| APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
| APO-DILTIAZ TZ | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1078 |